Cargando…

Survey of Australians using cannabis for medical purposes

BACKGROUND: The New South Wales State Government recently proposed a trial of the medical use of cannabis. Australians who currently use cannabis medicinally do so illegally and without assurances of quality control. Given the dearth of local information on this issue, this study explored the experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Swift, Wendy, Gates, Peter, Dillon, Paul
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262744/
https://www.ncbi.nlm.nih.gov/pubmed/16202145
http://dx.doi.org/10.1186/1477-7517-2-18
_version_ 1782125902855929856
author Swift, Wendy
Gates, Peter
Dillon, Paul
author_facet Swift, Wendy
Gates, Peter
Dillon, Paul
author_sort Swift, Wendy
collection PubMed
description BACKGROUND: The New South Wales State Government recently proposed a trial of the medical use of cannabis. Australians who currently use cannabis medicinally do so illegally and without assurances of quality control. Given the dearth of local information on this issue, this study explored the experiences of medical cannabis users. METHODS: Australian adults who had used cannabis for medical purposes were recruited using media stories. A total of 147 respondents were screened by phone and anonymous questionnaires were mailed, to be returned by postage paid envelope. RESULTS: Data were available for 128 participants. Long term and regular medical cannabis use was frequently reported for multiple medical conditions including chronic pain (57%), depression (56%), arthritis (35%), persistent nausea (27%) and weight loss (26%). Cannabis was perceived to provide "great relief" overall (86%), and substantial relief of specific symptoms such as pain, nausea and insomnia. It was also typically perceived as superior to other medications in terms of undesirable effects, and the extent of relief provided. However, nearly one half (41%) experienced conditions or symptoms that were not helped by its use. The most prevalent concerns related to its illegality. Participants reported strong support for their use from clinicians and family. There was almost universal interest (89%) in participating in a clinical trial of medical cannabis, and strong support (79%) for investigating alternative delivery methods. CONCLUSION: Australian medical cannabis users are risking legal ramifications, but consistent with users elsewhere, claim moderate to substantial benefits from its use in the management of their medical condition. In addition to strong public support, medical cannabis users show strong interest in clinical cannabis research, including the investigation of alternative delivery methods.
format Text
id pubmed-1262744
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12627442005-10-22 Survey of Australians using cannabis for medical purposes Swift, Wendy Gates, Peter Dillon, Paul Harm Reduct J Research BACKGROUND: The New South Wales State Government recently proposed a trial of the medical use of cannabis. Australians who currently use cannabis medicinally do so illegally and without assurances of quality control. Given the dearth of local information on this issue, this study explored the experiences of medical cannabis users. METHODS: Australian adults who had used cannabis for medical purposes were recruited using media stories. A total of 147 respondents were screened by phone and anonymous questionnaires were mailed, to be returned by postage paid envelope. RESULTS: Data were available for 128 participants. Long term and regular medical cannabis use was frequently reported for multiple medical conditions including chronic pain (57%), depression (56%), arthritis (35%), persistent nausea (27%) and weight loss (26%). Cannabis was perceived to provide "great relief" overall (86%), and substantial relief of specific symptoms such as pain, nausea and insomnia. It was also typically perceived as superior to other medications in terms of undesirable effects, and the extent of relief provided. However, nearly one half (41%) experienced conditions or symptoms that were not helped by its use. The most prevalent concerns related to its illegality. Participants reported strong support for their use from clinicians and family. There was almost universal interest (89%) in participating in a clinical trial of medical cannabis, and strong support (79%) for investigating alternative delivery methods. CONCLUSION: Australian medical cannabis users are risking legal ramifications, but consistent with users elsewhere, claim moderate to substantial benefits from its use in the management of their medical condition. In addition to strong public support, medical cannabis users show strong interest in clinical cannabis research, including the investigation of alternative delivery methods. BioMed Central 2005-10-04 /pmc/articles/PMC1262744/ /pubmed/16202145 http://dx.doi.org/10.1186/1477-7517-2-18 Text en Copyright © 2005 Swift et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Swift, Wendy
Gates, Peter
Dillon, Paul
Survey of Australians using cannabis for medical purposes
title Survey of Australians using cannabis for medical purposes
title_full Survey of Australians using cannabis for medical purposes
title_fullStr Survey of Australians using cannabis for medical purposes
title_full_unstemmed Survey of Australians using cannabis for medical purposes
title_short Survey of Australians using cannabis for medical purposes
title_sort survey of australians using cannabis for medical purposes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262744/
https://www.ncbi.nlm.nih.gov/pubmed/16202145
http://dx.doi.org/10.1186/1477-7517-2-18
work_keys_str_mv AT swiftwendy surveyofaustraliansusingcannabisformedicalpurposes
AT gatespeter surveyofaustraliansusingcannabisformedicalpurposes
AT dillonpaul surveyofaustraliansusingcannabisformedicalpurposes